IP Library Granted Patent US 9,205,209
Granted Patent B2
US 9,205,209 · App. 13/724,560 · Granted Dec 8, 2015

Delivery device and method

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,205,209
App. No.
13/724,560
Granted
Dec 8, 2015
Kind
B2
Abstract

A delivery device for and method of delivering substance, in particular a vaccine, to a mucosal surface within the oral cavity of a subject, the device comprising: a mouthpiece unit to be gripped in the mouth of a subject, wherein the mouthpiece unit is configured such that, on exhalation or attempted exhalation by the subject, a pressure is developed in the oral cavity which is such as to close the oropharyngeal velum of the subject; and an oral outlet unit including at least one outlet from which substance is in use delivered to a mucosal surface within the oral cavity of the subject.

Claims (25)

1. A delivery device for delivering substance to a mucosal surface within the oral cavity of a subject, the device comprising:

a mouthpiece unit to be gripped in the mouth of a subject, wherein the mouthpiece unit is configured such that, on exhalation or attempted exhalation by the subject into the mouthpiece unit, a pressure is developed in the oral cavity which closes the oropharyngeal velum of the subject;

an oral outlet unit including at least one substance outlet from which substance is delivered to a mucosal surface within the oral cavity of the subject when the subject exhales or attempts to exhale through the mouthpiece unit; and

a breath-actuated delivery unit including a substance supply unit which is actuatable to deliver substance from the at least one substance outlet.

2. The delivery device of claim 1 , wherein the mouthpiece unit comprises a mouthpiece which includes a flow channel through which the subject exhales to develop an exhalation air flow.

3. The delivery device of claim 2 , wherein the mouthpiece is configured to provide a flow resistance to the exhalation air flow to develop a pressure in the oral cavity which is such as to cause closure of the oropharyngeal velum of the subject.

4. The delivery device of claim 1 , wherein the mouthpiece unit is closed to the atmosphere, whereby the subject, on attempting to exhale through the mouthpiece, develops a pressure in the oral cavity which is such as to cause closure of the oropharyngeal velum of the subject.

5. The delivery device of claim 1 , wherein the mouthpiece unit comprises an oral outlet unit positioner for positioning the oral outlet unit in the oral cavity of the subject.

6. The delivery device of claim 5 , wherein the oral outlet unit positioner comprises a referencing member which, when the mouthpiece unit is gripped in the mouth of the subject, engages the hard palate of the oral cavity and references the position of the oral outlet unit such as to direct the oral outlet unit at a targeted mucosal surface.

7. The delivery device of claim 6 , wherein the referencing member is of fixed position relative to the oral outlet unit.

8. The delivery device of claim 6 , wherein the referencing member is movable relative to the mouthpiece such as to adopt a referencing position when the mouthpiece unit is gripped in the mouth of the subject.

9. The delivery device of claim 5 , wherein the oral outlet unit positioner comprises a tongue depressing member which, when the mouthpiece unit is gripped in the mouth of the subject, acts to depress the tongue.

10. The delivery device of claim 9 , wherein the tongue depressing member is movable relative to the mouthpiece such as to adopt a tongue depressing position when the mouthpiece unit is gripped in the mouth of the subject.

11. The delivery device of claim 5 , wherein the oral outlet unit positioner comprises at least one expandable cuff member which, when expanded, is configured to engage the hard palate of the oral cavity and reference the position of the oral outlet unit such as to direct the oral outlet unit at a targeted mucosal surface.

12. The delivery device of claim 11 , wherein the at least one expandable cuff member is further configured to act to depress the tongue.

13. The delivery device of claim 11 , wherein the at least one expandable cuff member is an inflatable member.

14. The delivery device of claim 13 , wherein the at least one expandable cuff member is operably coupled to the mouthpiece unit and is inflated on exhalation or attempted exhalation by the subject.

15. The delivery device of claim 1 , wherein the delivery unit further comprises a reflex-inducing fluid delivery unit for delivering a reflex-inducing fluid to the subject.

16. The delivery device of claim 1 , wherein the oral outlet unit includes at least one reflex-inducing fluid outlet from which a reflex-inducing fluid is delivered to the oral cavity of the subject, and the delivery unit comprises a reflex-inducing fluid supply unit for supplying a reflex-inducing fluid to the at least one reflex-inducing fluid outlet.

17. The delivery device of claim 1 , further comprising:

a nosepiece unit for fitting to a nostril of the subject; and

a nasal outlet unit for delivering the substance to the nasal airway of the subject.

18. The delivery device of claim 17 , wherein the nasal outlet unit includes at least one second substance outlet for delivering a second substance to the nasal airway of the subject.

19. The delivery device of claim 18 ,

wherein the substance supply unit is actuatable to deliver the substance from the at least one substance outlet of the oral outlet unit and a second substance supply unit is actuatable to deliver the at least one second substance outlet of the nasal outlet unit.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded May 21, 2025
From: BIOPHARMA CREDIT PLC, AS COLLATERAL AGENT
To: OPTINOSE INC.
Reel/Frame 071547/0979 →
CHANGE OF ADDRESS Recorded Jan 7, 2025
From: OPTINOSE, INC.
To: OPTINOSE, INC.
Reel/Frame 069833/0297 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 27, 2022
From: OPTINOSE AS
To: OPTINOSE INC
Reel/Frame 061546/0424 →
RELEASE OF SECURITY AGREEMENT RECORDED AT REEL 044976 FRAME 0505 Recorded Sep 13, 2019
From: ATHYRIUM OPPORTUNITIES III ACQUISITION LP
To: OPTINOSE AS
Reel/Frame 050371/0894 →
SECURITY INTEREST Recorded Sep 13, 2019
From: OPTINOSE AS
To: BIOPHARMA CREDIT PLC, AS COLLATERAL AGENT
Reel/Frame 050371/0913 →
SECURITY INTEREST Recorded Dec 29, 2017
From: OPTINOSE AS
To: ATHYRIUM OPPORTUNITIES III ACQUISITION LP
Reel/Frame 044976/0505 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 22, 2013
From: DJUPESLAND, PER GISLE
To: OPTINOSE AS
Reel/Frame 031065/0259 →